Cargando…

Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib

BACKGROUND: Molecular techniques are fundamental for establishing an accurate diagnosis and therapeutic approach of glycogen storage diseases (GSDs). We aimed to evaluate SLC37A4 mutation spectrum in Korean GSD Ib patients. METHODS: Nine Korean patients from eight unrelated families with GSD Ib were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Rihwa, Park, Hyung-Doo, Ko, Jung Min, Lee, Jeongho, Lee, Dong Hwan, Hong, Suk Jin, Ki, Chang-Seok, Lee, Soo-Youn, Kim, Jong-Won, Song, Junghan, Choe, Yon Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339099/ https://www.ncbi.nlm.nih.gov/pubmed/28224773 http://dx.doi.org/10.3343/alm.2017.37.3.261

Ejemplares similares

PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations
por: Choi, Rihwa, et al.
Publicado: (2016)

Mutation analysis of SLC37A4 in a patient with glycogen storage disease-type Ib
por: Zhang, Yamei, et al.
Publicado: (2019)

A Novel Mutation (A148V) in the Glucose 6-phosphate Translocase (SLC37A4) Gene in a Korean Patient with Glycogen Storage Disease Type 1b
por: Han, Sung-Hee, et al.
Publicado: (2005)

A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene
por: Choi, So Yoon, et al.
Publicado: (2018)

Does Type I Truly Dominate Hepatic Glycogen Storage Diseases in Korea?: A Single Center Study
por: Jeong, Yu Ju, et al.
Publicado: (2014)

Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates
por: Choi, Rihwa, et al.
Publicado: (2019)

Determining mutations in G6PC and SLC37A4 genes in a sample of Brazilian patients with glycogen storage disease types Ia and Ib
por: Carlin, Marcelo Paschoalete, et al.
Publicado: (2013)

A novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia
por: Dissanayake, Vajira HW, et al.
Publicado: (2011)

Novel GALT variations and mutation spectrum in the Korean population with decreased galactose-1-phosphate uridyltransferase activity
por: Choi, Rihwa, et al.
Publicado: (2014)

Glycogen Storage Disease Ib and Severe Periodontal Destruction: A Case Report
por: Ma, Rui, et al.
Publicado: (2018)

CYP21A2 Mutation Analysis in Korean Patients With Congenital Adrenal Hyperplasia Using Complementary Methods: Sequencing After Long-Range PCR and Restriction Fragment Length Polymorphism Analysis With Multiple Ligation-Dependent Probe Amplification Assay
por: Hong, Geehay, et al.
Publicado: (2015)

The natural history of glycogen storage disease type Ib in England: A multisite survey
por: Halligan, Rebecca, et al.
Publicado: (2021)

Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors
por: Murko, Simona, et al.
Publicado: (2023)

Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis
por: Yang, Mina, et al.
Publicado: (2017)

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
por: Wicker, Camille, et al.
Publicado: (2020)

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
por: Tallis, Eran, et al.
Publicado: (2022)

Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib
por: Du, Caiqi, et al.
Publicado: (2021)

A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia
por: Wang, Fengyu, et al.
Publicado: (2021)

Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023)

Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing
por: Choi, Rihwa, et al.
Publicado: (2017)

Interpretation of SLC3A1 and SLC7A9 variants in cystinuria patients: The significance of the PM3 criterion and protein stability
por: Lee, Beomki, et al.
Publicado: (2023)

Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre
por: Halligan, Rebecca K., et al.
Publicado: (2022)

The overall benefits of empagliflozin treatment in adult siblings with glycogen storage disease type Ib: one year experience
por: Bidiuk, Joanna, et al.
Publicado: (2022)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea
por: Choi, Rihwa, et al.
Publicado: (2019)

Final height of Korean patients with early treated congenital hypothyroidism
por: Lee, Jiyun, et al.
Publicado: (2018)

SLC37A1 and SLC37A2 Are Phosphate-Linked, Glucose-6-Phosphate Antiporters
por: Pan, Chi-Jiunn, et al.
Publicado: (2011)

Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2014)

Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia
por: Kim, Yoo-Mi, et al.
Publicado: (2020)

Glycogen storage disease type IV: a case report.
por: Lee, K. Y., et al.
Publicado: (1998)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
por: Grünert, Sarah C., et al.
Publicado: (2020)

Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report
por: Makrilakis, Konstantinos, et al.
Publicado: (2022)

A novel SLC37A4 missense mutation in GSD‐Ib without hepatomegaly causes enhanced leukocytes endoplasmic reticulum stress and apoptosis
por: Xu, Qianyun, et al.
Publicado: (2020)

Down-regulation of the IbEXP1 gene enhanced storage root development in sweetpotato
por: Noh, Seol Ah, et al.
Publicado: (2013)

The Characteristics and Outcomes of Abernethy Syndrome in Korean Children: A Single Center Study
por: Kim, Eun Sil, et al.
Publicado: (2019)

Clinical, Biochemical and Genetic Analyses in Two Korean Patients with Medium-chain Acyl-CoA Dehydrogenase Deficiency
por: Woo, Hye In, et al.
Publicado: (2011)

Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
por: Rossi, Alessandro, et al.
Publicado: (2021)

Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report
por: Calia, Margherita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_odprak1jud8s5javvncmjp1uhr